Xiaojing Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaojing Ma has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Rong Yang
Cornell University
7 shared publications - Jiayan Lang
Robert F. Smith School of Chemical & Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA
3 shared publications Pengyu Chen
Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14850, USA
3 shared publications- Pengyu Chen
Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA
3 shared publications - Wenjing Tang
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14850, USA
3 shared publications - Alexandra Khlyustova
Robert Frederick Smith School of Chemical and Biomolecular Engineering
2 shared publications
Latest Publications
- 18 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (837) , eadu9186
Neutrophil-mediated delivery of antibiotics across the tympanic membrane for otitis media treatment in a preclinical model
Acute otitis media (AOM) is a leading cause of pediatric antibiotic prescriptions. Systemic antibiotics cause side effects and antibiotic resistance, whereas local delivery of antibiotics (directly to the middle ear) is hindered by an impermeable biological barrier, the tympanic membrane (TM). Here, we developed hydroxylated liposomes that are internalized by neutrophils recruited during AOM to transport encapsulated ciprofloxacin across the intact TM. In mice, complement opsonization of the hydroxylated liposomes increased neutrophil uptake ex vivo and in vivo. In chinchillas with AOM induced by nontypeable Haemophilus influenzae , a hydrogel formulation containing the hydroxylated liposomes applied topically to the TM led to middle ear concentrations of ciprofloxacin that were 36-fold higher than those achieved by liposome-free hydrogels. The pathogens were undetectable within 24 hours, which compares favorably to the current 5- to 10-day treatment using oral antibiotics. The treated TM appeared identical to the pristine ones, and auditory brainstem response thresholds in healthy animals were unchanged by the treatment. Depleting complement proteins using cobra venom factor reduced the transtympanic delivery efficiency and led to a cure rate of 25%, implicating the essential role of complement opsonization in enabling neutrophil hitchhiking. Unlike previous immune cell–based delivery approaches, our method achieves neutrophil hitchhiking through a simple topical application of hydroxylated liposomes, thereby eliminating the need for invasive neutrophil harvesting. It points to a potential low-cost and noninvasive treatment for this prevalent disease, poised to reduce pediatric antibiotic usage.
- 18 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (837) , eadu9186
Neutrophil-mediated delivery of antibiotics across the tympanic membrane for otitis media treatment in a preclinical model
Acute otitis media (AOM) is a leading cause of pediatric antibiotic prescriptions. Systemic antibiotics cause side effects and antibiotic resistance, whereas local delivery of antibiotics (directly to the middle ear) is hindered by an impermeable biological barrier, the tympanic membrane (TM). Here, we developed hydroxylated liposomes that are internalized by neutrophils recruited during AOM to transport encapsulated ciprofloxacin across the intact TM. In mice, complement opsonization of the hydroxylated liposomes increased neutrophil uptake ex vivo and in vivo. In chinchillas with AOM induced by nontypeable Haemophilus influenzae , a hydrogel formulation containing the hydroxylated liposomes applied topically to the TM led to middle ear concentrations of ciprofloxacin that were 36-fold higher than those achieved by liposome-free hydrogels. The pathogens were undetectable within 24 hours, which compares favorably to the current 5- to 10-day treatment using oral antibiotics. The treated TM appeared identical to the pristine ones, and auditory brainstem response thresholds in healthy animals were unchanged by the treatment. Depleting complement proteins using cobra venom factor reduced the transtympanic delivery efficiency and led to a cure rate of 25%, implicating the essential role of complement opsonization in enabling neutrophil hitchhiking. Unlike previous immune cell–based delivery approaches, our method achieves neutrophil hitchhiking through a simple topical application of hydroxylated liposomes, thereby eliminating the need for invasive neutrophil harvesting. It points to a potential low-cost and noninvasive treatment for this prevalent disease, poised to reduce pediatric antibiotic usage.
- Open Access
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6310-6324
Transtympanic delivery of V 2 O 5 nanowires with a tympanic-membrane penetrating peptide
Vanadium pentoxide (V 2 O 5 ) nanowires were modified with trans-tympanic peptides for enhanced trans-tympanic permeability. The as-modified nanowires retain haloperoxidase-like catalytic activities that can be harnessed to combat otitis media pathogens.
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6310-6324
Open AccessTranstympanic delivery of V 2 O 5 nanowires with a tympanic-membrane penetrating peptide
Vanadium pentoxide (V 2 O 5 ) nanowires were modified with trans-tympanic peptides for enhanced trans-tympanic permeability. The as-modified nanowires retain haloperoxidase-like catalytic activities that can be harnessed to combat otitis media pathogens.
- 5 January 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (3) , 1014-1023
A cascade nanozyme with antimicrobial effects against nontypeable Haemophilus influenzae
A cascade nanozyme with glucose oxidase and haloperoxidase activities was designed and synthesized, which was shown to generate antiseptic HOBr from a ubiquitous non-ROS, O2. It successfully inhibited growth of a bacterial pathogen and its biofilm.
- 5 January 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (3) , 1014-1023
A cascade nanozyme with antimicrobial effects against nontypeable Haemophilus influenzae
A cascade nanozyme with glucose oxidase and haloperoxidase activities was designed and synthesized, which was shown to generate antiseptic HOBr from a ubiquitous non-ROS, O2. It successfully inhibited growth of a bacterial pathogen and its biofilm.
- 10 March 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (10) , 3731-3737
Haloperoxidase-mimicking CeO2−xnanorods for the deactivation of human coronavirus OC43
Schematic diagram of virucidal properties of haloperoxidase (HPO)-mimicking CeO2−x nanorods. CeO2−x nanorods catalysed the oxidative bromination of Br− and H2O2 to HOBr, which works as an antiseptic to kill viruses.
- 10 March 2022
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (10) , 3731-3737
Haloperoxidase-mimicking CeO2−xnanorods for the deactivation of human coronavirus OC43
Schematic diagram of virucidal properties of haloperoxidase (HPO)-mimicking CeO2−x nanorods. CeO2−x nanorods catalysed the oxidative bromination of Br− and H2O2 to HOBr, which works as an antiseptic to kill viruses.
- 4 February 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (14) , 2728-2739
Surfaces with antifouling-antimicrobial dual function via immobilization of lysozyme on zwitterionic polymer thin films
Due to the emergence of wide-spread infectious diseases, there is a heightened need for antimicrobial and/or antifouling coatings that can be used to prevent infection and transmission in a variety of applications, ranging from healthcare devices to public facilities. While antimicrobial coatings kill pathogenic bacteria upon contact with the surface, the antimicrobial function alone often lacks long-term effectiveness due to the accumulation of dead cells and their debris on the surface, thus reducing the performance of the coating over time. Therefore, it is desirable to develop coatings with the dual functions of antimicrobial efficacy and fouling resistance, in which antifouling coatings provide the added benefit of preventing the adhesion of dead cells and debris. Leveraging the outstanding antifouling properties of zwitterionic coatings, we synthesized copolymers with this antimicrobial-antifouling dual function by immobilizing lysozyme, a common antimicrobial enzyme, to the surface of a pyridinium-based zwitterionic copolymer. Specifically, poly(4-vinylpyridine-co-pentaflurophenyl methacrylate-co-divinyl benzene) [P(4VP-PFPMA-DVB)] thin films were synthesized by an all-dry vapor deposition technique, initiated Chemical Vapor Deposition, and derivatized using 1,3-propane sultone to obtain sulfobetaine moieties. Lysozyme, known to hydrolyze polysaccharides in the cell wall of Gram-positive bacteria, was immobilized by forming amide bonds with the copolymer coating via nucleophilic substitution of the pentafluorophenyl group. The antifouling and antibacterial performance of the novel lysozyme-zwitterionic coating was tested against Gram-positive Bacillus subtilis and Gram-negative Pseudomonas aeruginosa. A reduction in surface adhesion of 87% was achieved for P. aeruginosa, and of 75% for B. subtilis, when compared to a common poly(vinyl chloride) surface. The lysozyme-zwitterionic coating also deactivated 67% of surface-attached Gram-positive bacteria, B. subtilis. This novel dual-function material can produce anti-infection surfaces for medical devices and surgical tools, personal care products, and surfaces in public facilities.
- 4 February 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (14) , 2728-2739
Surfaces with antifouling-antimicrobial dual function via immobilization of lysozyme on zwitterionic polymer thin films
Due to the emergence of wide-spread infectious diseases, there is a heightened need for antimicrobial and/or antifouling coatings that can be used to prevent infection and transmission in a variety of applications, ranging from healthcare devices to public facilities. While antimicrobial coatings kill pathogenic bacteria upon contact with the surface, the antimicrobial function alone often lacks long-term effectiveness due to the accumulation of dead cells and their debris on the surface, thus reducing the performance of the coating over time. Therefore, it is desirable to develop coatings with the dual functions of antimicrobial efficacy and fouling resistance, in which antifouling coatings provide the added benefit of preventing the adhesion of dead cells and debris. Leveraging the outstanding antifouling properties of zwitterionic coatings, we synthesized copolymers with this antimicrobial-antifouling dual function by immobilizing lysozyme, a common antimicrobial enzyme, to the surface of a pyridinium-based zwitterionic copolymer. Specifically, poly(4-vinylpyridine-co-pentaflurophenyl methacrylate-co-divinyl benzene) [P(4VP-PFPMA-DVB)] thin films were synthesized by an all-dry vapor deposition technique, initiated Chemical Vapor Deposition, and derivatized using 1,3-propane sultone to obtain sulfobetaine moieties. Lysozyme, known to hydrolyze polysaccharides in the cell wall of Gram-positive bacteria, was immobilized by forming amide bonds with the copolymer coating via nucleophilic substitution of the pentafluorophenyl group. The antifouling and antibacterial performance of the novel lysozyme-zwitterionic coating was tested against Gram-positive Bacillus subtilis and Gram-negative Pseudomonas aeruginosa. A reduction in surface adhesion of 87% was achieved for P. aeruginosa, and of 75% for B. subtilis, when compared to a common poly(vinyl chloride) surface. The lysozyme-zwitterionic coating also deactivated 67% of surface-attached Gram-positive bacteria, B. subtilis. This novel dual-function material can produce anti-infection surfaces for medical devices and surgical tools, personal care products, and surfaces in public facilities.
- Open Access
- 14 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (2) , eabl8812
An imidazolium-based zwitterionic polymer for antiviral and antibacterial dual functional coatings
An imidazolium-based zwitterionic polymer is reported with dual functions of antivirus and antifouling with broad applicability.
- 14 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (2) , eabl8812
Open AccessAn imidazolium-based zwitterionic polymer for antiviral and antibacterial dual functional coatings
An imidazolium-based zwitterionic polymer is reported with dual functions of antivirus and antifouling with broad applicability.
- 24 September 2021
- Published by Wiley in AIChE Journal
- Vol. 67 (12)
Silver nanoparticles as an effective antimicrobial against otitis media pathogens
Otitis Media (OM) is the most common reason for US children to receive prescribed oral antibiotics, leading to be a potential to cause antibiotic resistance. To minimize oral antibiotic usage, we developed polyvinylpyrrolidone‐coated silver nanoparticles (AgNPs‐PVP), which completely eradicated common OM pathogens, that is, Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) at 1.04 and 2.13 μg/ml. The greater antimicrobial efficacy against S. pneumoniae was a result of the H2O2‐producing ability of S. pneumoniae and the known synergistic interactions between H2O2 and AgNPs. To enable the sustained local delivery of AgNPs‐PVP (e.g., via injection through perforated tympanic membranes), a hydrogel formulation of 18%(w/v) P407 was developed. Reverse thermal gelation of the AgNPs‐PVP‐P407 hydrogel could gel rapidly upon entering the warm auditory bullae and thereby sustained release of antimicrobials. This hydrogel‐based local delivery system completely eradicated OM pathogens in vitro without cytotoxicity, and thus represents a promising strategy for treating bacterial OM without relying on conventional antibiotics.
- 24 September 2021
- Published by Wiley in AIChE Journal
- Vol. 67 (12)
Silver nanoparticles as an effective antimicrobial against otitis media pathogens
Otitis Media (OM) is the most common reason for US children to receive prescribed oral antibiotics, leading to be a potential to cause antibiotic resistance. To minimize oral antibiotic usage, we developed polyvinylpyrrolidone‐coated silver nanoparticles (AgNPs‐PVP), which completely eradicated common OM pathogens, that is, Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) at 1.04 and 2.13 μg/ml. The greater antimicrobial efficacy against S. pneumoniae was a result of the H2O2‐producing ability of S. pneumoniae and the known synergistic interactions between H2O2 and AgNPs. To enable the sustained local delivery of AgNPs‐PVP (e.g., via injection through perforated tympanic membranes), a hydrogel formulation of 18%(w/v) P407 was developed. Reverse thermal gelation of the AgNPs‐PVP‐P407 hydrogel could gel rapidly upon entering the warm auditory bullae and thereby sustained release of antimicrobials. This hydrogel‐based local delivery system completely eradicated OM pathogens in vitro without cytotoxicity, and thus represents a promising strategy for treating bacterial OM without relying on conventional antibiotics.